TNFA

TNFA

USD

TNF Pharmaceuticals Inc. Common Stock

$5.200-0.430 (-7.638%)

Real-time Price

Technology
Computer hardware
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$5.630

High

$8.900

Low

$4.200

Volume

0.52M

Company Fundamentals

Market Cap

9.6M

Industry

Computer hardware

Country

United States

Trading Stats

Avg Volume

1.82M

Exchange

NCM

Currency

USD

52-Week Range

Low $3.24Current $5.200High $195

Related News

BusinessWire

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"

Licensed technology positions Company at forefront of new quantum-class computing paradigm

View more
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
BusinessWire

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing

New trading symbol QCLS effective Thursday, September 25, 2025 Licensed technology positions Company at forefront of new quantum-class computing paradigm TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("Q/C" or the

View more
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol "QCLS" to Reflect Strategic Focus on Quantum Class Photonic Computing
BusinessWire

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals Inc. (NASDAQ:TNFA), ("TNF" or the "Company") today announced that it received written notice from the Nasdaq Stock Market on September 16, 2025, confirming that the Company has regained compliance

View more
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
BusinessWire

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Management to present on Wednesday, September 10, 2025, at 8:00 a.m. ET TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company") today announced its participation in the H.C. Wainwright & Co. 27th Annual

View more
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference